Skip to Content
Merck

Key Documents

View All Documentation

504955-30

Discovery® C18 (5 µm) HPLC Columns

L × I.D. 15 cm × 3 mm, HPLC Column

Synonym(s):

C18 TM=["Discovery"] HPLC Column

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
L × i.d.:
15 cm × 3 mm
Particle size:
5 μm
Matrix active group:
C18 (RP18), C18 (octadecyl) phase
Pore size:
180 Å
Matrix:
silica gel, high purity, spherical particle platform, fully porous particle
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Discovery® C18 HPLC Column, 5 μm particle size, L × I.D. 15 cm × 3 mm

material

stainless steel column

Quality Segment

100

agency

suitable for USP L1

product line

Discovery®

feature

endcapped

manufacturer/tradename

Discovery®

packaging

1 ea of

extent of labeling

12% Carbon loading

parameter

≤70 °C temp. range, 400 bar pressure (5801 psi)

technique(s)

HPLC: suitable, LC/MS: suitable

L × I.D.

15 cm × 3 mm

surface area

300 m2/g

surface coverage

3 μmol/m2

impurities

<10 ppm metals

matrix

silica gel, high purity, spherical particle platform, fully porous particle

matrix active group

C18 (RP18), C18 (octadecyl) phase

particle size

5 μm

pore size

180 Å

operating pH range

2-8

application(s)

food and beverages

separation technique

reversed phase

General description

Use Discovery® C18 for any method that specifies a C18. The exceptional peak shape, reproducibility, and stability make it the column of choice for all C18 methods from demanding to routine.

Application


  • A stability indicating RP-HPLC method for determination of the COVID-19 drug molnupiravir applied using nanoformulations in permeability studies.: This paper describes the use of the Discovery® C18 HPLC Column in developing a stability-indicating method for the COVID-19 therapeutic, molnupiravir, emphasizing its critical role in supporting pandemic response through advanced drug formulation and analysis (Recber et al., 2022).

  • Features of assay and decomposition dynamics of 2-methoxy-4-(1-propenyl)hydroxybenzene in biological material.: Demonstrates the versatility of the Discovery® C18 HPLC Column in forensic science, particularly in the analysis and decomposition studies of complex organic compounds within biological samples (Chernova et al., 2022).

Features and Benefits

  • Excellent reproducibility
  • Exceptional peak shape for basic and acidic analytes
  • Stable, low-bleed LC-MS separations
  • Separation of peptides and small proteins
  • Lower hydrophobicity than many comparable C18 columns, providing faster analysis

Other Notes

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

Still not finding the right product?

Explore all of our products under Discovery® C18 HPLC Column

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library